ArticleBlood advances2025

TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation.

Konstantinos Lontos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.